price month
short-term focu growth margin reiter outperform
rate tp sfr ascom report fy detail figur
right in-lin compani guidanc ebitda margin
revenu growth organ ebitda margin excl
one-off outlook revenu growth
ebitda margin in-lin around fell slightli short
ebitda margin assumpt conserv guidanc
impact invest lag us busi new product
ascom platform ascom myco slightli
reduc estim revenu ebitda view
share price reaction harsh remain posit follow reason
us weak address result lower end guidanc
complet attribut weak us indirect distribut channel
manag chang sale forc built
improv order dynam ascom result skew toward
show even clearer improv order side
intak yoy order intak support growth
softwar servic outgrow group ascom improv
revenu mix faster growth softwar servic vs
total revenu lead margin improv time
strong product pipelin ascom invest myco
myco launch new ascom platform
product push growth cost slightli margin
valuat believ ev/ebitda reflect
potenti ascom term growth cash gener return
valuat metric
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
ascom global leader develop distribut
healthcar commun solut nurs call system
soft- middle-war well end-devic myco
base ascom reach guidanc
addit expect ascom year deliv result
mid-term guidanc ebitda margin
boost higher proport softwar servic revenu
driven expect higher revenu softwar
servic higher margin
scenario ascom abl grow line healthcar
ict market take compani much
longer transit hardwar softwar solut
supplier lead lower growth lower margin ebitda
margin lower cash contribut would appli
ev/ebitda multipl in-lin smid industri
price rel chart measur perform swiss market
ind close
spot exchang rate
market leader ascom market leader critic commun healthcar
industri global market share defin market nurs call system
soft- middlewar purpos built end-devic accord consult firm
healthcar market set grow next year look compani
larger healthcar busi like ge siemen phillip lot
potenti market ascom address issu hospit alarm fatigu
replac paper base process electron medic record much year
compani attract project hospit around world
prove us need ascom product busi leverag
also asia almost present ascom strong partnership confirm
posit view product posit partnership ge draeger
guidanc estim compani want achiev revenu growth
doubl digit growth healthcar alon revenu current
ebitda margin target around product mix need improv
toward softwar view strong disbelief market ascom
achiev target compani disappoint lot last year
given shi outlook offer good opportun investor trust
manag board achiev target view estim
revenu compound-annual-growth-rate ep compound-annual-growth-rate
period improv ebitda margin mainli driven reduc
cost base posit impact around sfr gross improv mix toward
ascom potenti target interest thought us also ascom could
acquisit target compani high yield go
current strong posit grow market
manag want larg acquisit ascom could becom target
disbelief market opportun reason view share price
reflect potenti futur growth margin expans lie fact
compani disappoint lot past talk investor sens
consider disbelief invest stori view clear ascom
achiev target market grow demand
digitalization/cost optim increas safeti hospit ascom leader
fragment market interest product market obvious
compani chang new manag product orient
compani solut orient compani servic revenu high
expect softwar revenu move well ascom also prove past
grow busi least high singl digit ebitda margin
busi asset light product facil oper high margin
healthcar environ valuat move closer compani similar
set-up posit name awar risk attach
stori need certain belief manag potenti patienc
retain outperform rate tp believ ascom remain
attract case outlin made averag chang ebitda
estim switch estim retain
tp sfr base dcf valu multipl comparison peer
see valuat section would recommend build posit depress share
fy figur outlook
fy in-lin expect
mention ascom deliv promis although compani
benefit minor posit provis effect ebitda line adjust
ebitda margin would therefor slightli guidanc
 focu section particularli weak spot us
weak us blame shi
typic compani undergo signific chang alway
obstacl one would expect fy ascom ran problem us busi
result disappoint declin revenu geographi roughli
busi saw increas revenu sinc us second
largest end-market ascom weak result caus shi fy
us flat vs declin group revenu growth would around
margin would higher posit side
book-to-bil us improv posit indic
weak address cost margin
seem us local manag us realiz on-going
weak indirect channel sale therefor made wrong judgement full
year develop group manag ascom made chang local
manag replac januari expect ascom quickli start
work follow issu
sale channel expect ascom push direct sale channel away
indirect sale channel us difficult clear control
obvious need hire sale peopl result slightli higher sg
tailor solut north america us market need tailor
solut hospit market seem function slightli differ vs european
market ascom intend develop tailor solut us might
indic higher cost
strateg partnership view key point us busi strong
strateg partner help ascom attack market current strong
partnership
first step taken digistat due introduc us proprietari softwar
ascom alreadi success use european hospit collect patient data
medic devic patient monitor ventil infus pump real-tim
fed electron medic record due introduc us
us attract market ascom could imagin
competit moment region look compani
vocera zebra technolog nevertheless ascom success us
project date compar competit believ offer
compel much broader see high probabl us recov
servic softwar develop clear posit
besid clear neg develop us also clear sign ascom
right track grow revenu margin mid-term believ
ascom need grow busi revenu softwar servic
compani report strong increas revenu
figur softwar servic revenu
outlook conserv focu growth
two main reason sharp share price reaction view outlook
indic ebitda margin move best fact
target reach small posit one-off view neg
market
would agre compani openli commun
small one-off effect also see make huge differ ebitda
margin sinc one-off result cheaper reorgan
even posit point seen
outlook
outlook rais question growth side see problem
order intak indic revenu growth rather upper end
compani guidanc critic investor could argu growth rate still step
away target us real critic point ascom
alway said need time get complet product set-up right captur
growth margin howev slightli surpris expect
compani report improv year year see ebitda margin around
therefor ebitda margin guidanc stabl
conserv view believ reason invest
new product ascom/elderli platform ascom myco
larger direct sale forc us sg
mid-term guidanc still unchang fire market
ascom stick mid-term guidanc revenu growth
ebitda margin around target current fire market
compani miss opportun show real margin improv also
guidanc differ around margin
target quit larg compani also mention earlier
see hockey stick margin develop steadi improv
market adjust hockey stick develop view compani
focus top-lin growth cost coupl bp ebitda margin
see mid-term target still realist ascom shown almost everi year
larg oper leverag effect busi model usual
revenu higher vs ebitda margin move significantli
pro-forma ascom onecompani basi move
show possibl growth acceler
beyond mid-term
although ascom yet proven get mid-term target still think
interest look beyond next year strongli believ ascom one
best product servic mix market benefit even drive digit
healthcar hardwar combin proprietari softwar allow complet
solut healthcar hospit also elderli home care
healthcar ict market expect grow around compound-annual-growth-rate see reason
ascom abl grow revenu least pace
compani also push softwar servic could even see ebitda
margin potenti move mark
estim valuat
section take closer look estim chang valuat ascom
chang estim
adjust estim back fy
report figur think invest distribut product weigh
margin see posit trend kicking-in
model slightli higher cost year distribut
averag ebitda estim move sinc public fy
figur share lost reflect much smaller earn
revis view
believ ascom reach ebitda margin close year depend
much need invest distribut new product path
toward target becom slightli steeper expect revenu growth
acceler product mix shift toward softwar servic margin
ascom trade roughli ev/ebitda price-to-earnings multipl
reflect revenu growth potenti margin expans potenti compani
opinion cash gener also high ascom forecast return profil
look highli attract compar peer group ascom run high price-to-earnings discount
high ev/ebitda discount includ vocera
comparison discount even larger
credit suiss estim thomson reuter datastream consensu vocera nexu cse ascom
look dcf share also show clear potenti upsid
end chang net normal tax rate net net chang net net debt net pension valu per reportedtransit periodend periodwacc calculationrevenu interest market net net net net net net sale changen nwc chang net chang net rate rate rate periodtransit periodwaccwaccassumptionsequ valu sensitivitiestermin growth rateend period ebit charl martineau pm univers toronto
compani mention price
michael inauen patrick laager certifi respect compani secur individu analyz view express
report accur reflect person view subject compani secur part compens
directli indirectli relat specif recommend view express report
